Хайлтын үр дүнгүүд - Nancy Whiting
- 4-н 1 - 4 үр дүнгүүдийг харуулж байна
-
1
A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma -н M. A. Hussein, James R. Berenson, Rubén Niesvizky, Nikhil C. Munshi, J. Matouš, Ronald Sobecks, Kate Harrop, Jonathan G. Drachman, Nancy Whiting
Хэвлэсэн 2010Artigo -
2
Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma -н Ranjana H. Advani, Andres Forero‐Torres, Richard R. Furman, Joseph D. Rosenblatt, Anas Younes, Hong Ren, Kate Harrop, Nancy Whiting, Jonathan G. Drachman
Хэвлэсэн 2009Artigo -
3
SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer -н Django Sussman, Leia M. Smith, Martha E. Anderson, Steve Duniho, Joshua H. Hunter, Heather Kostner, Jamie B. Miyamoto, Albina Nesterova, Lori Westendorf, Heather A. Van Epps, Nancy Whiting, Dennis R. Benjamin
Хэвлэсэн 2014Artigo -
4
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors -н Sven de Vos, Andres Forero‐Torres, Stephen M. Ansell, Brad S. Kahl, Bruce D. Cheson, Nancy L. Bartlett, Richard R. Furman, Jane N. Winter, Henry G. Kaplan, John M. Timmerman, Nancy Whiting, Jonathan G. Drachman, Ranjana H. Advani
Хэвлэсэн 2014Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Adverse effect
Cancer
Gastroenterology
Lymphoma
Pharmacokinetics
Anemia
Antibody
Antibody-drug conjugate
Astrobiology
Biology
Biotechnology
Breast cancer
Cancer research
Chimeric antigen receptor
Clinical trial
Cohort
Correlative
Cytokine release syndrome
Diffuse large B-cell lymphoma
Dosing
Hematology
Immunology
Immunotherapy
In vivo
Lenalidomide
Linguistics
Maximum tolerated dose
Melanoma